Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06275412 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Family Intervention for Black Teens With Type 1 Diabetes

Study acronym: 3Ms
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Re-verified, no change to tracked fieldsv7
  2. Site details revised at 4 of 4 sitesv6
  3. Primary and study completion dates: Mar 2028 to Apr 30, 2028v5
  4. Start date: Jul 15, 2024 to Sep 16, 2024v4
  5. Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 3 to 4
    • Start date changed from estimate of Jul 2024 to Jul 15, 2024
    v3
  6. Start date: Jun 2024 to Jul 2024v2
  7. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of this study is to conduct a multicenter, randomized effectiveness trial of The 3Ms 2.0 compared to an educational control condition for improving adolescent glycemic control and diabetes-related family relationships and reducing primary caregiver diabetes-related distress among Black adolescents with type 1 diabetes (T1D) and their primary caregivers. The proposed study would develop and test The 3Ms 2.0 adapted intervention when delivered using a mobile health approach (accessed via parents' cell phone). The intervention will also include new family intervention content (videoclips and text messages).
Trial Details
NCT Number NCT06275412
Lead Sponsor Wayne State University
Collaborators: National Institute on Minority Health and Health Disparities (NIMHD)
Conditions
(from sponsor)		 Type 1 Diabetes, Family Relations
Related terms Diabetes Mellitus, Type 1
Enrollment 216 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov